Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 6c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.75), $0.06 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Lumentum shares rise on analyst upgrades, AI demand outlook
• Jana Partners urges Cooper Companies to replace CEO and explore asset sales